Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Rani Therapeutics Holdings (RANI) Long-Term Debt Issuances (2020 - 2022)

Rani Therapeutics Holdings (RANI) has 3 years of Long-Term Debt Issuances data on record, last reported at $14.9 million in Q4 2022.

  • For Q4 2022, Long-Term Debt Issuances rose 766.45% year-over-year to $14.9 million; the TTM value through Dec 2023 reached $29.6 million, changed 0.0%, while the annual FY2022 figure was $29.6 million, 1619.42% up from the prior year.
  • Long-Term Debt Issuances reached $14.9 million in Q4 2022 per RANI's latest filing, up from $14.7 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $14.9 million in Q4 2022 and bottomed at -$1.7 million in Q3 2021.
  • Average Long-Term Debt Issuances over 3 years is $5.7 million, with a median of $2.3 million recorded in 2020.
  • Peak YoY movement for Long-Term Debt Issuances: tumbled 38.15% in 2021, then surged 952.97% in 2022.
  • A 3-year view of Long-Term Debt Issuances shows it stood at $2.8 million in 2020, then crashed by 38.15% to $1.7 million in 2021, then skyrocketed by 766.45% to $14.9 million in 2022.
  • Per Business Quant database, its latest 3 readings for Long-Term Debt Issuances were $14.9 million in Q4 2022, $14.7 million in Q3 2022, and $1.7 million in Q4 2021.